Serum zinc levels in pediatric patients with COVID-19
Prospective study of 100 COVID+ pediatric patients in Turkey, showing significantly increased risk of hospitalization for patients with zinc deficiency.
risk of hospitalization, 75.3% lower, RR 0.25, p = 0.01, high zinc levels (≥70μg/dL) 10 of 89 (11.2%), low zinc levels (<70μg/dL) 5 of 11 (45.5%), NNT 2.9.
|
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
|
Ekemen Keleş et al., 22 Jan 2022, prospective, Turkey, peer-reviewed, 7 authors, study period 3 August, 2020 - 15 November, 2020.
Abstract: European Journal of Pediatrics
https://doi.org/10.1007/s00431-021-04348-w
ORIGINAL ARTICLE
Serum zinc levels in pediatric patients with COVID‑19
Yıldız Ekemen Keleş1 · Dilek Yılmaz Çiftdoğan2 · Ayfer Çolak3 · Ahu Kara Aksay1 · Gülnihan Üstündag1 ·
Aslıhan Şahin1 · Nisel Yılmaz4
Received: 26 May 2021 / Revised: 18 November 2021 / Accepted: 13 December 2021
© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021
Abstract
Zinc has potent immunoregulatory and antiviral effects that are critical for growth, immunity, and neurologic development.
The aim of this study was to determine the clinical significance of serum zinc levels in pediatric patients with COVID19 and to demonstrate its association with disease severity. This prospective observational study was conducted between
August 3 and November 15, 2020, in pediatric patients aged 1 month to 18 years with confirmed COVID-19 using reverse
transcription-polymerase chain reaction. We defined a control group whose serum zinc levels were determined 1 year ago
at the same time as those of patients with COVID-19. We used 70 μg/dL as the cut-off zinc value to define zinc deficiency.
Statistical analyses were performed using the SPSS for Windows statistics package program. One hundred children with
confirmed COVID-19 and 269 children in the control group participated in the study. The median age was 13.3 (IQR:
8–15.4) years in patients with confirmed COVID-19, 11 patients had low serum zinc levels, and 89 patients had normal
serum zinc levels. Patients in the group with low zinc levels had a significantly higher hospitalization rate than the group
with normal zinc levels (5 (45.5%) and 10 patients (11.2%), respectively) (p = 0.011). The median serum zinc level in
patients with COVID-19 was 88.5 mcg/dL (IQR 77.2–100), which was significantly lower than the median level in the
control group, which was 98 mcg/dL (IQR 84–111) (p = 0.001). There was no association between the severity of COVID19 and the serum zinc levels of the children.
Conclusion: Serum zinc levels may be influenced by many factors such as fasting status, diurnal variation, exercise, and
sex, and may give an impression of the zinc status of the population rather than reflecting the individual. The fact that the
incidence of hospitalization was significantly higher in patients with both COVID-19 and low serum zinc levels suggests
that these patients require a detailed assessment of their living environment.
What is Known:
• Serum zinc levels have been found to be low in adult patients diagnosed with COVID-19.
• There was a correlation between the severity of COVID-19 and serum zinc levels in adults.
What is New:
• Children with low serum zinc levels were found to have a higher number of hospitalizations.
• No association was found between the severity of COVID-19 disease and serum zinc levels in children.
Keywords Children · COVID-19 · Zinc · SARS-CoV-2
Keymessage PediatricCOVID-19 populations with low serum
zinc levels may have an increased incidenceof hospitalization,
and physicians are advised to exercise caution in thisregard.
Communicated by Nicole Ritz
* Yıldız Ekemen Keleş
kutupylz@hotmail.com
Extended author information available on the last page of the article
Abbreviations
SARS-CoV-2 Severe acute respiratory syndrome
coronavirus-2
COVID-19 Coronavirus Disease-19
RT-PCR Reverse transcription-polymerase chain
reaction
IZiNCG International Zinc Nutrition..
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation.
FLCCC and
WCH
provide treatment protocols.
Submit